Benzoyl Peroxide vs Adapalene for Molluscum Contagiosum
Trial Summary
What is the purpose of this trial?
This trial tests two treatments for children with molluscum contagiosum. One treatment uses benzoyl peroxide to kill germs and dry out bumps. The other uses adapalene to reduce swelling and prevent new bumps. The goal is to see which treatment clears the skin better over a few months.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to discuss this with the trial coordinators or your doctor.
How does the drug Adapalene Gel, Benzoyl Peroxide differ from other treatments for molluscum contagiosum?
Research Team
Jason Hirshburg, MD
Principal Investigator
University of Oklahoma
Eligibility Criteria
This trial is for children aged 1 to 14 with molluscum contagiosum who haven't been treated before. It's open to those whose parents want treatment and can consent, but not for kids who've had reactions to topical retinoids or benzoyl peroxide, among others.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either adapalene 0.1% gel or benzoyl peroxide 10% applied 1-2 times daily as tolerated
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Adapalene Gel
- Benzoyl peroxide
Adapalene Gel is already approved in United States, European Union, Canada, Japan for the following indications:
- Acne vulgaris
- Acne vulgaris
- Seborrhoeic keratoses
- Acne vulgaris
- Acne vulgaris
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor